APA citáció

Pinczés László Imre, Szabó Roxána, Illés Árpád, Földeák Dóra Melinda, Piukovics Klára, Szomor Árpád, . . . Miltényi Zsófia. (2020). Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma.

Chicago Style (17th ed.) Citation

Pinczés László Imre, Szabó Roxána, Illés Árpád, Földeák Dóra Melinda, Piukovics Klára, Szomor Árpád, Gopcsa László, and Miltényi Zsófia. Real-world Efficacy of Brentuximab Vedotin Plus Bendamustine as a Bridge to Autologous Hematopoietic Stem Cell Transplantation in Primary Refractory or Relapsed Classical Hodgkin Lymphoma. 2020.

MLA idézés

Pinczés László Imre, et al. Real-world Efficacy of Brentuximab Vedotin Plus Bendamustine as a Bridge to Autologous Hematopoietic Stem Cell Transplantation in Primary Refractory or Relapsed Classical Hodgkin Lymphoma. 2020.